Projects funded by the NCN
Analysis of immungenecity and therapeutic activity of cell cancer vaccines based on cancer stem cells and induced pluripotent stem cells in mouse melanoma model.
2012/07/B/NZ6/03495
Keywords:
melanoma immunotherapy cancer stem cells induced pluripotent stem cells
Descriptors:
- NZ6_8: Other related subjects
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 4 - announced on 2012-09-15
Amount awarded: 993 270 PLN
Project start date (Y-m-d): 2013-07-08
Project end date (Y-m-d): 2017-07-07
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Equipment purchased [PL]
- Czytnik do ELISPOT do testów enzymatycznych i fluorescencyjnych (190 000 PLN)
Information in the final report
- Publication in academic press/journals (2)
- Immunotargeting of cancer stem cellsAuthors:Kwiatkowska-Borowczyk EP, Gąbka-Buszek A, Jankowski J, Mackiewicz AAcademic press:Contemporary Oncology (Poznan) (rok: 2015, tom: 19, strony: 52-59), Wydawca: TermediaStatus:PublishedDOI:10.5114/wo.2014.47129 - link to the publication
- Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanoshere-Derived Stem-Like Cells Display High Efficacy in murine Tumor Rejection ModelAuthors:Gąbka-Buszek A, Kwiatkowska-Borowczyk E, Jankowski J, Kozłowska A.K, Mackiewicz AAcademic press:Vaccines (rok: 2020, tom: 8, strony: 147 (nr artykułu. brak numerów stron)), Wydawca: MDPI, Basel, SwitzerlandStatus:PublishedDOI:10.3390/vaccines8020147 - link to the publication